Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

SANTINI, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.712
AS - Asia 1.679
EU - Europa 1.407
SA - Sud America 253
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 8.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.672
SG - Singapore 688
RU - Federazione Russa 466
CN - Cina 402
IT - Italia 271
BR - Brasile 185
HK - Hong Kong 162
DE - Germania 149
VN - Vietnam 144
PL - Polonia 106
GB - Regno Unito 84
FR - Francia 83
FI - Finlandia 61
JP - Giappone 54
BD - Bangladesh 46
IE - Irlanda 44
SE - Svezia 43
IN - India 35
KR - Corea 29
AR - Argentina 24
CA - Canada 21
UA - Ucraina 19
TR - Turchia 18
AT - Austria 17
EC - Ecuador 17
ES - Italia 16
IQ - Iraq 16
IR - Iran 14
NL - Olanda 13
MA - Marocco 12
PK - Pakistan 11
UZ - Uzbekistan 11
EG - Egitto 10
RO - Romania 10
VE - Venezuela 10
MX - Messico 9
ZA - Sudafrica 9
CI - Costa d'Avorio 8
BE - Belgio 7
ID - Indonesia 7
KE - Kenya 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
CO - Colombia 5
DO - Repubblica Dominicana 5
PY - Paraguay 5
CL - Cile 4
LT - Lituania 4
SA - Arabia Saudita 4
TN - Tunisia 4
AL - Albania 3
BH - Bahrain 3
JO - Giordania 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
BG - Bulgaria 2
CR - Costa Rica 2
ET - Etiopia 2
LB - Libano 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
PE - Perù 1
RS - Serbia 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 8.111
Salva come PNG Salva come JPEG
Città #
Fairfield 750
Ashburn 581
Singapore 424
Woodbridge 347
Houston 293
Seattle 287
Wilmington 256
Cambridge 225
Chandler 217
San Jose 172
Hong Kong 155
Ann Arbor 116
Moscow 97
Zgierz 89
Council Bluffs 79
Beijing 76
Los Angeles 67
Medford 67
Altamura 59
Chicago 53
Tokyo 49
Ho Chi Minh City 46
Lauterbourg 46
Helsinki 45
Dublin 44
Lawrence 42
Princeton 42
Des Moines 39
London 37
Hanoi 35
New York 35
Hefei 34
Dearborn 33
Nanjing 32
Palermo 32
Santa Clara 32
San Diego 31
Ludwigshafen am Rhein 27
Dallas 26
Frankfurt am Main 26
Boardman 24
São Paulo 24
Salt Lake City 23
Panama City 22
Phoenix 22
Seoul 22
Rome 21
Berlin 18
Buffalo 18
The Dalles 18
Shenyang 16
Elk Grove Village 15
Nanchang 15
Changsha 14
Denver 13
Jinan 13
Orem 13
San Paolo di Civitate 13
Atlanta 12
Chennai 12
Nuremberg 12
Brooklyn 11
Da Nang 11
Hebei 11
Izmir 11
Milan 11
Warsaw 11
Guangzhou 10
Tampa 10
Tianjin 10
Cairo 9
Tehran 9
Abidjan 8
Montreal 8
Schiffdorf 8
Shanghai 8
Tulsa 8
Amsterdam 7
Brussels 7
Hangzhou 7
Redwood City 7
Tashkent 7
Baghdad 6
Guayaquil 6
Haiphong 6
Jiaxing 6
Nairobi 6
Vienna 6
Biên Hòa 5
Detroit 5
Düsseldorf 5
Falkenstein 5
Johannesburg 5
Lappeenranta 5
Lucera 5
Mexico City 5
Ninh Bình 5
Orange 5
Quito 5
Saint Petersburg 5
Totale 5.788
Salva come PNG Salva come JPEG
Nome #
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 344
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 322
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 277
Update on capecitabine alone and in combination regimens in colorectal cancer patients 270
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. 267
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 254
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 245
Lack of Correlation between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: A Retrospective Study 240
Cetuximab in small bowel adenocarcinoma: A new friend 227
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis 225
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 224
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 222
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 221
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 219
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 214
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 211
Deregulation of dicer and mir-155 expression in liposarcoma 211
New molecular targets in bone metastases 210
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 201
Hepatocellular carcinoma treatment over sorafenib: Epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? 192
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter 188
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 187
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules 187
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 177
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 170
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: A new pharmacodynamic marker? 160
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential 153
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas 151
The dark side of the moon: The PI3K/PTEN/AKT pathway in colorectal carcinoma 150
Pharmacogenomics of cetuximab in metastatic colorectal carcinoma 150
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary 150
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 149
Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment † 142
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 141
Recent advances in desmoid tumor therapy 140
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 139
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 135
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies 128
The use of same in chemotherapy-induced liver injury 125
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 112
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 111
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 108
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens 102
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 88
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 85
Small bowel carcinomas in celiac or Crohn's disease: Distinctive histophenotypic, molecular and histogenetic patterns 59
null 3
Totale 8.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 0 57
2021/2022555 32 123 25 13 8 17 25 38 45 69 79 81
2022/2023691 64 173 14 51 62 96 29 64 77 6 37 18
2023/2024270 20 30 32 15 17 33 35 9 2 4 3 70
2024/20251.044 14 85 46 47 23 56 63 103 57 114 240 196
2025/20262.874 274 104 179 223 360 381 410 339 269 166 137 32
Totale 8.386